TrialAmerican journal of nephrology2017

Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease.

Vicente E Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.